Univariate | Multivariate analysis | |||||
---|---|---|---|---|---|---|
 | Moderate to severe steatosis | Mild steatosis | P value | OR | 95% CI | P value |
Age (year) | 51.90 ± 9.94 | 47.41 ± 11.27 | 0.207 |  |  |  |
Sex (male/female) | 10/10 | 13/4 | 0.098 | Â | Â | Â |
Height (cm) | 167.10 ± 11.55 | 169.41 ± 9.23 | 0.511 |  |  |  |
Weight (kg) | 86 ± 16.89 | 74.76 ± 16.47 | 0.049 |  |  |  |
BMI (kg/m2) | 30.81 ± 5.11 | 25.99 ± 5.38 | 0.008 | 1.055 | 0.855–1.301 | 0.620 |
WC (cm) | 109.74 ± 11.74 | 99.29 ± 9.95 | 0.006 | 1.062 | 0.953–1.183 | 0.276 |
AST (IU/L) | 21.62 ± 9.4 | 23.92 ± 13.61 | 0.590 |  |  |  |
ALT (IU/L) | 24.43 ± 11.76 | 26.57 ± 13.74 | 0.650 |  |  |  |
PTDM | 57.9% | 64.7% | 0.676 | Â | Â | Â |
Post-transplant HLP | 47.4% | 47.1% | 0.985 | Â | Â | Â |
Post-transplant HTN | 42.1% | 35.3% | 0.676 | Â | Â | Â |
Rejection | 36.7% | 34.5% | 0.839 | Â | Â | Â |
Mean prednisolone dose (mg) | 8.26 ± 3.87 | 7.20 ± 3.74 | 0.379 |  |  |  |
TM6SF2 genotype | ||||||
 CT + TT versus CC | 75% | 76.5% | 0.917 |  |  |  |
PCSK9 genotype | ||||||
 AG + GG versus AA | 65% | 17.6% | 0.004 | 5.747 | 1.086–30.303 | 0.040 |
PCSK7 genotype | ||||||
 CT + TT versus CC | 65% | 88.2% | 0.101 |  |  |  |